首页 | 本学科首页   官方微博 | 高级检索  
检索        


OVARIAN ELECTROCAUTERY VERSUS HUMAN MENOPAUSAL GONADOTROPHINS AND PURE FOLLICLE STIMULATING HORMONE THERAPY IN THE TREATMENT OF PATIENTS WITH POLYCYSTIC OVARIAN DISEASE
Authors:AHMED ABDEL GADIR  RAOUF S MOWAFI  HUDA M I ALNASER  ABDULLA H ALRASHID  ONEZI M ALONEZI  ROBERT W SHAW
Abstract:Eighty-eight clomiphene citrate-resistant infertile patients with oligomeno-rrhoea or amenorrhoea attributable to polycystic ovarian disease were divided at random into three groups. Twenty-nine patients were treated with ovarian electrocautery, 30 with human menopausal gonadotropins (hMG) and 29 with pure follicle stimulating hormone (FSH). Successful ovulation was induced in 71-4, 70-6 and 66-7% of the cycles in the groups respectively. Ten patients conceived after electrocautery and pure FSH therapy while 15 conceived after hMG medication (chi-squared = 1 -6464, P = 0–439). The six-cycle cumulative pregnancy rate in the three consecutive groups was 521, 55-4 and 38-3%. Four further pregnancies were achieved after treating 10 patients in the electrocautery group with clomiphene citrate (100 mg/day for 5 days) for 25 cycles. The rate of pregnancy wastage in the corresponding groups was 21-4, 53-3 and 40% (chi-squared = 3–127, P = 0–2039). Ovarian electrocautery is equally effective as hMG and pure FSH in the treatment of PCO patients resistant to clomiphene citrate therapy.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号